Talking Points

Episode 170: The ADAPT-TAVR Trial

Informações:

Sinopsis

Duk-Woo Park and C. Michael Gibson discuss edoxaban vs dual antiplatelet therapy for valve thrombosis and cerebral thromboembolism after TAVI.